story of the week
Efficacy of Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
N. Engl. J. Med 2024 Oct 31;391(17)1584-1596, NC Turner, SA Im, C Saura, D Juric, S Loibl, K Kalinsky, P Schmid, S Loi, P Sunpaweravong, A Musolino, H Li, Q Zhang, Z Nowecki, R Leung, E Thanopoulou, N Shankar, G Lei, TJ Stout, KE Hutchinson, JL Schutzman, C Song, KL JhaveriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.